What was intent behind the MDCG guidance for Biological Equivalence and how did it help?

Equivalence started getting noticed around 2007 and 2008 with some particular device failures. Back then, there was a much lighter approach to biological equivalence. From that time, they determined that they want materials for implants to be the same – not just similar or lower risk.


We are passionate about your success. Tell us more about your regulatory and quality needs so we can help.

Book a Consultation

GLOBAL BOTTOM CTA INSTRUCTIONS:

To display custom copy instead of global copy in this section, please go to Show Global Content for Bottom CTA? toggle in the "Contents" tab to the left, toggle it off, save, and then REFRESH the page editor, the custom text will then show up and ready to be edited.

Turning the global content back on will be the same process, go to the toggle and toggle it back on, save and refresh!